By proceeding, you agree to our Terms of Use and Privacy Policy.
The 20th European Neurofibromatosis Meeting will be held in Manchester UK in October 2022 as a face to face conference.
The 20th European Neurofibromatosis Meeting will be an opportunity to foster new research collaborations on the most advanced research on neurofibromatosis.
Explore insights on epidemiology of NF1 and NF2 in Finland and molecular diagnosis of mosaic disease in the NF1 clinic.
Discover strategies to navigate through key neuroradiological features in paediatric NF1 and NF2.
Convenzis is a family run company with many years of combined experience across the team in the events industry, we are our proud to provide conferences, summits and dinners.
Brainlab is a digital medical technology pioneer founded in 1989 and headquartered in Munich. The company employs more than 2000 people in 25 locations around the globe.
The Children’s Tumor Foundation is a 501(c)(3) not-for-profit organization dedicated to funding and driving innovative research that will result in effective treatments for the millions of people worldwide living with neurofibromatosis (NF), a term
Nerve Tumours UK is the authoritative voice of over 26,000 people in the UK who are born with one of the neurofibromatoses. The charity seeks to expand knowledge of neurofibromatosis and nerve tumours and advance the care for those with the condition
Nerve Tumours UK is the authoritative voice of over 26,000 people in the UK who are born with one of the neurofibromatoses. The charity seeks to expand knowledge of neurofibromatosis and nerve tumours and advance the care for those with the condition.
All trademarks, registered trademarks, product names, and company names or logos mentioned in or on this site are the property of their respective owners.
A great community. Legit content. The kind of emails you actually look forward to.